Replies to post #186261 on Biotech Values

[ghmm]

The Promoting Life-Saving New Therapies for Neonates Act of 2015: A New Twist on Transferable Vouchers

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/09/the-promoting-life-saving-new-therapies-for-neonates-act-of-2015-a-new-twist-on-transferable-voucher.html

There’s also the concept of so-called “wildcard exclusivity” proposed in one version of the 21st Century Cures Act. A provision in the bill would allow a sponsor to convey a portion of its exclusivity to apply with respect to one or more other drugs (see our previous post here). Such conveyance could include the sale of exclusivity from one company to another company and would also apply to Orange Book-listed patents.